147 related articles for article (PubMed ID: 22832064)
21. Sapropterin. Phenylketonuria: for a minority of patients.
Prescrire Int; 2010 Jun; 19(107):101-4. PubMed ID: 20738029
[TBL] [Abstract][Full Text] [Related]
22. [Tetrahydrobiopterin loading test in differential diagnosis among hyperphenylalaninemia patients].
Zhang ZX; Ye J; Qiu WJ; Han LS; Gu XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):438-40. PubMed ID: 16086286
[TBL] [Abstract][Full Text] [Related]
23. [Studies on neonatal screening, clinical and gene analysis for tetrahydrobiopterin deficiency in Southern Chinese].
Ye J; Liu X; Ma X; Huang X; Zhang Y; Gu X; Chen R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):92-5. PubMed ID: 11295124
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment.
Levy H; Burton B; Cederbaum S; Scriver C
Mol Genet Metab; 2007 Dec; 92(4):287-91. PubMed ID: 18036498
[TBL] [Abstract][Full Text] [Related]
25. Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy.
Lambruschini N; Pérez-Dueñas B; Vilaseca MA; Mas A; Artuch R; Gassió R; Gómez L; Gutiérrez A; Campistol J
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S54-60. PubMed ID: 16040265
[TBL] [Abstract][Full Text] [Related]
26. Recommendations for the use of sapropterin in phenylketonuria.
Cunningham A; Bausell H; Brown M; Chapman M; DeFouw K; Ernst S; McClure J; McCune H; O'Steen D; Pender A; Skrabal J; Wessel A; Jurecki E; Shediac R; Prasad S; Gillis J; Cederbaum S
Mol Genet Metab; 2012 Jul; 106(3):269-76. PubMed ID: 22575621
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan.
Okano Y; Kudo S; Nishi Y; Sakaguchi T; Aso K
J Hum Genet; 2011 Apr; 56(4):306-12. PubMed ID: 21307867
[TBL] [Abstract][Full Text] [Related]
28. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
[TBL] [Abstract][Full Text] [Related]
29. A hypothesis on the biochemical mechanism of BH(4)-responsiveness in phenylalanine hydroxylase deficiency.
Steinfeld R; Kohlschütter A; Ullrich K; Lukacs Z
Amino Acids; 2003 Jul; 25(1):63-8. PubMed ID: 12836060
[TBL] [Abstract][Full Text] [Related]
30. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
[TBL] [Abstract][Full Text] [Related]
31. Effect of tetrahydrobiopterin on Phe/Tyr ratios and variation in Phe levels in tetrahydrobiopterin responsive PKU patients.
Humphrey M; Nation J; Francis I; Boneh A
Mol Genet Metab; 2011; 104(1-2):89-92. PubMed ID: 21624843
[TBL] [Abstract][Full Text] [Related]
32. [Screening of tetrahydrobiopterin deficiency among hyperphenylalaninemic patients].
Dhondt JL; Hayte JM
Ann Biol Clin (Paris); 2002; 60(2):165-71. PubMed ID: 11937441
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience.
Opladen T; Abu Seda B; Rassi A; Thöny B; Hoffmann GF; Blau N
J Inherit Metab Dis; 2011 Jun; 34(3):819-26. PubMed ID: 21416196
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and effectiveness of pramipexole in tetrahydrobiopterin deficiency.
Porta F; Ponzone A; Spada M
Eur J Paediatr Neurol; 2016 Nov; 20(6):839-842. PubMed ID: 27562098
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Zurflüh MR; Zschocke J; Lindner M; Feillet F; Chery C; Burlina A; Stevens RC; Thöny B; Blau N
Hum Mutat; 2008 Jan; 29(1):167-75. PubMed ID: 17935162
[TBL] [Abstract][Full Text] [Related]
36. Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life.
Ziesch B; Weigel J; Thiele A; Mütze U; Rohde C; Ceglarek U; Thiery J; Kiess W; Beblo S
J Inherit Metab Dis; 2012 Nov; 35(6):983-92. PubMed ID: 22391997
[TBL] [Abstract][Full Text] [Related]
37. Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria.
Steinfeld R; Kohlschütter A; Ullrich K; Lukacs Z
J Inherit Metab Dis; 2004; 27(4):449-53. PubMed ID: 15303001
[TBL] [Abstract][Full Text] [Related]
38. Spotlight on sapropterin in primary hyperphenylalaninemia.
Sanford M; Keating GM
BioDrugs; 2009; 23(3):201-2. PubMed ID: 19627172
[TBL] [Abstract][Full Text] [Related]
39. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
[TBL] [Abstract][Full Text] [Related]
40. Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency.
Jäggi L; Zurflüh MR; Schuler A; Ponzone A; Porta F; Fiori L; Giovannini M; Santer R; Hoffmann GF; Ibel H; Wendel U; Ballhausen D; Baumgartner MR; Blau N
Mol Genet Metab; 2008 Mar; 93(3):295-305. PubMed ID: 18060820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
